Do These 3 Checks Before Buying Winner Medical Co., Ltd. (SZSE:300888) For Its Upcoming Dividend
Do These 3 Checks Before Buying Winner Medical Co., Ltd. (SZSE:300888) For Its Upcoming Dividend
Winner Medical Co., Ltd. (SZSE:300888) stock is about to trade ex-dividend in 3 days. Typically, the ex-dividend date is one business day before the record date which is the date on which a company determines the shareholders eligible to receive a dividend. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn't show on the record date. In other words, investors can purchase Winner Medical's shares before the 4th of June in order to be eligible for the dividend, which will be paid on the 4th of June.
稳健医疗股票将于3天内分红,通常分红日是指公司确定有资格收到分红的股东的日期的前一天,而分红日就是重要的日期,因为在该日期之后或之日购买该股票可能意味着迟到的结算,因此投资者需要在6月4日之前购买稳健医疗的股份才能享受分红。
The company's upcoming dividend is CN¥0.50 a share, following on from the last 12 months, when the company distributed a total of CN¥0.50 per share to shareholders. Last year's total dividend payments show that Winner Medical has a trailing yield of 1.7% on the current share price of CN¥29.96. If you buy this business for its dividend, you should have an idea of whether Winner Medical's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.
该公司即将发放0.50元人民币的股息,过去的一年中,该公司向股东分配的总股息为0.50元人民币每股,去年的总股息支付显示稳健医疗在当前股价29.96元人民币的收益率为1.7%。如果您因其股息而购买此业务,您应该知道稳健医疗的股息是否可靠且可持续。这就是为什么我们总是应该检查分红支付是否看起来可持续,同时检查公司是否在成长。
Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. It paid out 77% of its earnings as dividends last year, which is not unreasonable, but limits reinvestment in the business and leaves the dividend vulnerable to a business downturn. We'd be concerned if earnings began to decline. A useful secondary check can be to evaluate whether Winner Medical generated enough free cash flow to afford its dividend. It paid out an unsustainably high 209% of its free cash flow as dividends over the past 12 months, which is worrying. Unless there were something in the business we're not grasping, this could signal a risk that the dividend may have to be cut in the future.
股息通常来自公司盈利。如果公司支付的股息超过了其盈利,则股息可能是不可持续的。去年,它支付了其盈利的77%作为股息,这不是不合理的,但是会限制业务再投资,并使股息容易受到业务下滑的影响。如果收益开始下降,我们将会担忧。一个有用的次要检查可以是评估稳健医疗是否产生足够的自由现金流来支付其股息。过去12个月中,它将不可持续的高达209%的自由现金流作为股息支付,这是令人担忧的。除非我们没有掌握业务中的某些内容,否则这可能表明未来将有股息风险。
Winner Medical does have a large net cash position on the balance sheet, which could fund large dividends for a time, if the company so chose. Still, smart investors know that it is better to assess dividends relative to the cash and profit generated by the business. Paying dividends out of cash on the balance sheet is not long-term sustainable.
稳健医疗在资产负债表上拥有大量的净现金,这可以为其提供足够的资金支付大额股息,如果公司选择如此的话。然而,明智的投资者知道,最好相对于业务产生的现金和利润来评估股息。从资产负债表上的现金支付股息不是长期可持续的。
While Winner Medical's dividends were covered by the company's reported profits, cash is somewhat more important, so it's not great to see that the company didn't generate enough cash to pay its dividend. Cash is king, as they say, and were Winner Medical to repeatedly pay dividends that aren't well covered by cashflow, we would consider this a warning sign.
尽管稳健医疗的股息得到了公司报告利润的覆盖,但现金比起利润更重要,因此看到公司没有产生足够的现金来支付其股息并不好。正如人们所说,现金就是王者,如果稳健医疗反复支付未由现金流充分支持的股息,这将被视为警告信号。
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
点击此处查看公司的支付比率以及未来分红的分析师预期。
![historic-dividend](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240531/0-21627a3790b1a8a65fe73d84be6a866d-0-be1a9d0c6c6ca42ed5e4fcee005b8a39.png/big)
Have Earnings And Dividends Been Growing?
收益和股息一直在增长吗?
Businesses with shrinking earnings are tricky from a dividend perspective. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. So we're not too excited that Winner Medical's earnings are down 4.1% a year over the past five years.
从股息角度来看,收益下降的企业是棘手的。如果企业进入低谷并削减股息,该公司的价值可能会急剧下跌。过去五年中,稳健医疗的收益年均下降4.1%,这让我们感到不太兴奋。
The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. Winner Medical has seen its dividend decline 27% per annum on average over the past three years, which is not great to see. While it's not great that earnings and dividends per share have fallen in recent years, we're encouraged by the fact that management has trimmed the dividend rather than risk over-committing the company in a risky attempt to maintain yields to shareholders.
大多数投资者评估公司的股息前景的主要方式是检查股息增长的历史情况。过去三年中,稳健医疗的股息平均下降了27%,这看起来并不乐观。尽管近年来每股收益和股息下降并不是件好事,但我们很高兴看到管理层减少了股息而不是冒险过度承诺,以维持股东的收益。
To Sum It Up
总结一下
Is Winner Medical an attractive dividend stock, or better left on the shelf? Winner Medical had an average payout ratio, but its free cash flow was lower and earnings per share have been declining. It's not that we think Winner Medical is a bad company, but these characteristics don't generally lead to outstanding dividend performance.
稳健医疗是一只有吸引力的股息股票,还是更好地避开?稳健医疗具有平均的业绩派息比率,但其自由现金流较低,每股收益也一直在下降。不是说我们认为稳健医疗是一家糟糕的公司,但这些特征通常不会带来卓越的股息表现。
With that being said, if you're still considering Winner Medical as an investment, you'll find it beneficial to know what risks this stock is facing. Case in point: We've spotted 2 warning signs for Winner Medical you should be aware of.
话虽如此,如果您正在考虑将稳健医疗作为投资,您会发现了解该股面临的风险是有益的。例如:我们已发现两个稳健医疗的警示信号,您应该知晓。
If you're in the market for strong dividend payers, we recommend checking our selection of top dividend stocks.
如果你在寻找强劲的股息支付者,我们建议查看我们的顶级股息股票选择。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?关于内容有所顾虑?直接和我们联系。或电邮 editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。